Skip to main navigation

About People Science Pipeline Patients Investors Careers

Overview
Vision & Values
Impact
Founder's Letter
Contact

Overview
Leadership Team
Board of Directors
Scientific Advisory Board
R&D Advisory Board

RAS/MAPK Pathway
MAPKlamp & More
Presentations & Publications

Pipeline
Programs
Clinical Trials

Patients & Caregivers
Clinical Trials

Corporate Overview
News & Events
Stock Information
Corporate Governance
Financial Information
Investor Resources

Dynamic Culture
Values & Attributes
Competitive Benefits
Open Positions

Stay in Touch

858.465.6511
info@erasca.com

News & Events

News Releases
Erasca in the News
Events
Presentations

News Releases

Year

05.31.2023

Erasca to Host Virtual Investor Event on Pipeline Updates with a Focus on ERAS-007 ERK Inhibitor

05.25.2023

Erasca to Present Promising Preliminary HERKULES-3 Phase 1b Data at the 2023 ASCO Annual Meeting

05.16.2023

Erasca Further Strengthens Business Leadership with Two Key Promotions

05.15.2023

Erasca Reports First Quarter 2023 Financial Results and Business Updates

05.02.2023

Erasca to Present at the Bank of America Securities 2023 Health Care Conference

05.01.2023

Erasca Granted FDA Fast Track Designation for CNS-Penetrant EGFR Inhibitor ERAS-801 in Patients with Glioblastoma

04.26.2023

Erasca Announces Two Poster Presentations at the 2023 ASCO Annual Meeting

04.25.2023

Erasca Announces Publication of Promising Clinical Data Supporting the Therapeutic Potential of Naporafenib in Combination with Trametinib in NRAS-Mutant Melanoma

04.18.2023

Erasca Presents Promising Initial Phase 1b Dose Escalation Data from FLAGSHP-1 for ERAS-601 Plus Cetuximab in Patients with Advanced Solid Tumors at the 2023 AACR Annual Meeting

04.10.2023

Erasca Strengthens Clinical and Regulatory Leadership with Two Key Appointments as Company Transitions to Late-Stage Development

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Next page
Last page

Displaying 11 - 20 of 24

Site - Investor Tools

Contact Us

info@erasca.com

Location

ERASCA, INC.

3115 Merryfield Row

Suite 300

San Diego, CA 92121

Terms of Use
Privacy Policy

© 2021 Erasca™, Inc. All rights reserved.